CO5271723A1 - Forma triturada - Google Patents

Forma triturada

Info

Publication number
CO5271723A1
CO5271723A1 CO00091394A CO00091394A CO5271723A1 CO 5271723 A1 CO5271723 A1 CO 5271723A1 CO 00091394 A CO00091394 A CO 00091394A CO 00091394 A CO00091394 A CO 00091394A CO 5271723 A1 CO5271723 A1 CO 5271723A1
Authority
CO
Colombia
Prior art keywords
ethoxy
shredded form
tertbutoxycarbonylaminophenyl
mfi
jpeg
Prior art date
Application number
CO00091394A
Other languages
English (en)
Inventor
Hallgren Agneta
Roos Kristina
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of CO5271723A1 publication Critical patent/CO5271723A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una forma de partícula de tamaño reducido de ácido 3-{4-(2-(4-tercbutoxi carbonilaminofenil) etoxi)fenil}-(S)-2-etoxi propiónico como se muestra en la fórmula I abajo<EMI FILE="00091394_1" ID="1" IMF=JPEG >o sales farmacéuticamente aceptables del mismo o un solvato o cualquiera de los dos.
CO00091394A 1999-12-03 2000-11-29 Forma triturada CO5271723A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9904412A SE9904412D0 (sv) 1999-12-03 1999-12-03 Comminuted form

Publications (1)

Publication Number Publication Date
CO5271723A1 true CO5271723A1 (es) 2003-04-30

Family

ID=20417977

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00091394A CO5271723A1 (es) 1999-12-03 2000-11-29 Forma triturada

Country Status (5)

Country Link
AR (1) AR026705A1 (es)
AU (1) AU2034701A (es)
CO (1) CO5271723A1 (es)
SE (1) SE9904412D0 (es)
WO (1) WO2001040166A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
CN1280574A (zh) 1997-10-27 2001-01-17 雷迪研究基金会 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
BR9812770A (pt) 1997-10-27 2000-12-12 Reddy Research Foundation Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos
PL193086B1 (pl) 1997-10-27 2007-01-31 Reddys Lab Ltd Dr Nowe związki tricykliczne i związki pośrednie, sposób ich wytwarzania, zawierające je kompozycje farmaceutyczne oraz ich zastosowanie
CZ2001826A3 (cs) 1998-10-29 2001-08-15 Dr. Reddy's Research Foundation Zlepšený způsob přípravy nových antidiabetických prostředků
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
AR026705A1 (es) 2003-02-26
AU2034701A (en) 2001-06-12
SE9904412D0 (sv) 1999-12-03
WO2001040166A1 (en) 2001-06-07

Similar Documents

Publication Publication Date Title
CO5271736A1 (es) Forma triturada
CO5570109A1 (es) Compuestos de dihidropirimidina heterociclicos
CO5261539A1 (es) Compuestos farmaceuticamente activos
CO5271723A1 (es) Forma triturada
DK2316831T3 (da) 2-(Morpholin-4-yl)pyrimidiner som phosphotidylinositol (PI)-3-kinaseinhibitorer samt deres anvendelse ved behandling af cancer
ES2193205T3 (es) Nuevas bencil pirimidinas.
CY1117930T1 (el) Ανασετραπιμπη και αλλοι αναστολεις cetp
CO5251405A1 (es) 2-(3,5-bis-trifluorometil-fenil)-n-metil-n-(6-morfolin-4-il- 4-o-tolil-piridin-3-il)-isobutiramida
CY1105055T1 (el) Θepαπεια γαστρεντepικων στρωματικων ογκων
CO5160324A1 (es) Inhibidores de metaloproteasas n-hidroxi-4-{[4-(4-{6-[2-hidroxietoxi]piridin-2-il}-3-metil fenil)piperidin-1-il]sulfonil}tetrahidro-2h-piran-4-carboxa mida
EA200600381A1 (ru) Метансульфонат этилового эфира 3-[(2-{[4-(гексилоксикарбониламиноиминометил)фениламино]метил}-1-метил-1н-бензимидазол-5-карбонил)пиридин-2-иламино]пропионовой кислоты и его применение в качестве лекарственного средства
CO5200832A1 (es) Derivados de acidos heterociclicos, o una sal farmaceuticamente aceptable de los mismos, que son agentes antidiabeticos y antiobesidad
CR6682A (es) Inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorios, autoinmunes y respiratorias
TR200003543T2 (tr) Yeni 3-aril-2-hidroksipropiyonik asit türevi III.
AU3957800A (en) Crystalline r- guanidines, arginine or (l) -arginine (2(s)) -2- ethoxy -3-(4- (2-(10(h) -phenoxazin -10-yl)ethoxy}phenyl)propanoate
CO5460265A1 (es) Compuestos quimicos
HRP20080226T3 (en) Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
AP9901442A0 (en) 4-(2-Keto-1-benzimidazolinyl) piperidine compounds as orl1-receptor agonists.
CO5271666A1 (es) Derivados de pirimidina
CO5261565A1 (es) Inhibidores de n-(5-(((5-alquil-2-oxazolil)metil)tio)-2-tiazolil)-carboxamida de cinasas dependientes de ciclina
CA2425199A1 (en) Formulation of substituted benzimidazoles
CO5180572A1 (es) Una nueva forma cristalina de clorhidrato de 6-hidroxi-3- (4-[2-(piperidin-1-il)etoxi]fenoxi)-2-(4-metoxifenil)benzo [b]tiofeno
CO5280055A1 (es) Inhibidores de aminotransferasa dependiente de aminoacidos de cadena ramificada y su uso en el tratamiento de la retinopatia diabetica
CY1107300T1 (el) Ακυλικα παραγωγα της 5-(2-(4-(1,2-βενζισοθειαζολ-3-υλο)-1-πιπεραζινυλ)αιθυλο)-6-χλωρο-1,3-διυδρο-2h-ινδολ-2-ονης με νευροληπτικη δραστικοτητα
CO5150193A1 (es) DIHIDROXIACIDO ABIERTO Y SALES DE INHIBIDORES DE LA HMG-CoA REDUCTASA

Legal Events

Date Code Title Description
FA Application withdrawn